[ESPR] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
22-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -66.39%
YoY- -120.67%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -45,219 -43,337 -40,541 -28,956 -17,402 -14,035 -14,585 112.47%
Tax 606 433 482 423 488 494 457 20.67%
NP -45,219 -43,337 -40,541 -28,956 -17,402 -14,035 -14,585 112.47%
Tax Rate - - - - - - - -
Total Cost 45,219 43,337 40,541 28,956 17,402 14,035 14,585 112.47%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -1.86 -1.92 -1.80 -1.28 -0.77 -0.62 -0.65 101.42%
EPS Diluted -1.86 -1.92 -1.80 -1.28 -0.77 -0.62 -0.65 101.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.